DCF — HIGHLINE MEDICAL CENTER
Enterprise Value: $-149.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-149.3M
Enterprise Value
$-49.9M
PV of Cash Flows
$-99.3M
PV of Terminal Value
$-160.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $173.8M | $-7.8M | -5.0% | $-15.2M | $-13.8M |
| Year 2 | $179.1M | $-6.3M | -4.0% | $-13.8M | $-11.4M |
| Year 3 | $184.4M | $-4.6M | -3.0% | $-12.4M | $-9.3M |
| Year 4 | $190.0M | $-3.8M | -2.0% | $-11.8M | $-8.1M |
| Year 5 | $195.7M | $-3.4M | -2.0% | $-11.7M | $-7.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-149.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$168.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000296232784
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5